Merck (NYSE:MRK) has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine CAPVAXIVE®, boosting its portfolio in the vaccines market. Despite ...
5 天
Stocktwits on MSNMerck Enters $2B License Agreement With China-Based Hengrui Pharma For Heart Disease Drug ...Merck & Co., Inc. (MRK) said on Tuesday that it hasentered into an exclusive license agreement with China-based Jiangsu ...
In a strategic move to enhance its manufacturing capabilities, Merck has inaugurated a new $1 billion vaccine manufacturing facility in Durham, North Carolina. This facility is part of Merck’s ...
In the Carolinas, wildfires have set 11,314 acres ablaze, and two of the biggest fires in North Carolina are responsible for at least half of that. Both South Carolina and North Carolina have ...
In another development, Merck has opened a $1 billion vaccine manufacturing facility in Durham, North Carolina, to strengthen its U.S. manufacturing capabilities. The facility incorporates ...
The investment will be used to improve R&D infrastructure to develop new treatments and implement new technologies to improve ...
The wildfire burning Thursday in western North Carolina is now the "highest priority fire in the U.S," the state Forest Service said as millions of residents across the parched region remained ...
President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...
Pressure may grow on companies to repatriate production, raising production costs and potentially medicine prices too.
He won the top prize. Real-time updates and all local stories you want right in the palm of your hand. Part of the McClatchy Media Network ...
The decision was based on the lack of substantial evidence to support the claims. In another development, Merck has opened a $1 billion vaccine manufacturing facility in Durham, North Carolina, to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果